Rubedo Life Sciences Funding: $46M Raised, Series A (2024)
Rubedo Life Sciences is a Biotech company based in Palo Alto, California. It has raised $46M in total funding. Latest round: Series A.
Rubedo Life Sciences funding overview
Rubedo Life Sciences is a Biotech company based in Palo Alto, California. Rubedo Life Sciences has raised $46M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in April 2024. The round record for Rubedo Life Sciences runs through 2024; nothing later has been disclosed. Investors on record include Khosla Ventures, Ahren Innovation Capital, CDP Ventures. 3 distinct backers are named across the disclosed rounds.
Frequently asked about Rubedo Life Sciences funding
How much has Rubedo Life Sciences raised?
Rubedo Life Sciences has raised $46M in total disclosed funding across the rounds on record.
Who has invested in Rubedo Life Sciences?
Khosla Ventures, Ahren Innovation Capital, CDP Ventures are named among the investors backing Rubedo Life Sciences.
What was the latest Rubedo Life Sciences funding round?
The most recent disclosed round is a Series A, announced in April 2024.
Where is Rubedo Life Sciences based?
Rubedo Life Sciences is based in Palo Alto, California.
What sector does Rubedo Life Sciences operate in?
Rubedo Life Sciences is tracked under Biotech from Palo Alto, California, with $46M in disclosed funding.
When did Rubedo Life Sciences last raise?
The last disclosed Rubedo Life Sciences round closed in April 2024 at Series A.
Round data for Rubedo Life Sciences is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Palo Alto and backer lists below.
